TILT Holdings (TLLTF) Shares Outstanding (Diluted Average) (2021 - 2025)

TILT Holdings (TLLTF) reported Shares Outstanding (Diluted Average) of $391.3 million for Q2 2025, up 1.08% on a YoY basis from $387.1 million in Q2 2024, and little changed quarter-over-quarter from $391.3 million in Q1 2025.

TILT Holdings (TLLTF) Shares Outstanding (Diluted Average) (2021 - 2025) Analysis & Trends

TILT Holdings has reported Shares Outstanding (Diluted Average) for 5 years, with the latest figure at $391.3 million in Q2 2025.

  • For the quarter ending Q2 2025, Shares Outstanding (Diluted Average) rose 1.08% year-over-year to $391.3 million; the trailing twelve-month figure through Jun 2025 stood at $391.3 million (up 1.08% YoY), and the FY2024 full-year result was $388.7 million, up 2.4% from the prior year.
  • Shares Outstanding (Diluted Average) for Q2 2025 stood at $391.3 million, roughly flat from $391.3 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $461.1 million in Q2 2021, with the low at $370.0 million in Q4 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $388.4 million across 5 years, with a median of $382.7 million in 2023.
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) slipped 18.56% — and 2024, when it advanced 2.9%.
  • TILT Holdings' Shares Outstanding (Diluted Average) stood at $370.0 million in 2021, then climbed by 1.49% to $375.5 million in 2022, then gained by 1.09% to $379.6 million in 2023, then climbed by 2.4% to $388.7 million in 2024, then gained by 0.66% to $391.3 million in 2025.
  • The last three Shares Outstanding (Diluted Average) figures came in at $391.3 million (Q2 2025), $391.3 million (Q1 2025), and $388.7 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.18 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 47.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 103.40 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 TILT Holdings - - 1.82 Mn 391.28 Mn

Historic Data

Download Data
DateValue
Jun 30, 2025 391.28 Mn
Mar 31, 2025 391.25 Mn
Dec 31, 2024 388.71 Mn
Sep 30, 2024 389.52 Mn
Jun 30, 2024 387.10 Mn
Mar 31, 2024 385.72 Mn
Dec 31, 2023 379.58 Mn
Sep 30, 2023 378.54 Mn
Jun 30, 2023 378.30 Mn
Mar 31, 2023 377.70 Mn
Dec 31, 2022 375.50 Mn
Sep 30, 2022 375.31 Mn
Jun 30, 2022 375.54 Mn
Dec 31, 2021 370.00 Mn
Sep 30, 2021 409.70 Mn
Jun 30, 2021 461.12 Mn